Skip to main content
PMC home page
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1994 Jun 1;179(6):1847–1854. doi: 10.1084/jem.179.6.1847

Simultaneous expression of tissue factor and tissue factor pathway inhibitor by human monocytes. A potential mechanism for localized control of blood coagulation

PMCID: PMC2191520  PMID: 8195712

Abstract

Cells of monocytic lineage can initiate extravascular fibrin deposition via expression of blood coagulation mediators. This report is about experiments on three mechanisms with the potential to modulate monocyte- initiated coagulation. Monocyte procoagulant activity was examined as a function of lipid cofactor, protein cofactor, and specific inhibitor expression during short-term culture in vitro. Lipid cofactor activity was measured as the initial rate of factor X activation by intrinsic- pathway components, the assembly of which depends on this cofactor. Lipid cofactor activity levels changed by < 30% during 48-h culture. Protein cofactor, i.e., tissue factor (TF) antigen was measured by enzyme immunoassay. It increased from 461 pg/ml to a maximum value of 3,550 pg/ml at 24 h and remained at 70% of this value. Specific TF activity, measured as factor VII-dependent factor X activation rate, decreased from 54 to 18 nM FXa/min between 24 and 48 h. TF activity did not correlate well with either lipid cofactor or TF protein levels. In contrast, the decrease in TF activity coincided in time with maximal expression of tissue factor pathway inhibitor (TFPI) mRNA, which was determined using reverse transcriptase polymerase chain reaction (RT- PCR), and with maximal TFPI protein levels measured by immunoassay. The number of mRNA copies coding for TFPI and TF in freshly isolated blood monocytes were 46 and 20 copies/cells, respectively. These values increased to 220 and 63 copies/cell during short-term cell culture in the presence of endotoxin. Results demonstrate concomitant expression by monocytes of genes coding for both the essential protein cofactor and the specific inhibitor of the extrinsic coagulation pathway. Together with functional and antigenic analyses, they also imply that the initiation of blood clotting by extravascular monocyte/macrophages can be modulated locally by TFPI independently of plasma sources of the inhibitor.

Full Text

The Full Text of this article is available as a PDF (1,000.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bajaj M. S., Kuppuswamy M. N., Saito H., Spitzer S. G., Bajaj S. P. Cultured normal human hepatocytes do not synthesize lipoprotein-associated coagulation inhibitor: evidence that endothelium is the principal site of its synthesis. Proc Natl Acad Sci U S A. 1990 Nov;87(22):8869–8873. doi: 10.1073/pnas.87.22.8869. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bauldry S. A., McCall C. E., Cousart S. L., Bass D. A. Tumor necrosis factor-alpha priming of phospholipase A2 activation in human neutrophils. An alternative mechanism of priming. J Immunol. 1991 Feb 15;146(4):1277–1285. [PubMed] [Google Scholar]
  3. Brunk C. F., Jones K. C., James T. W. Assay for nanogram quantities of DNA in cellular homogenates. Anal Biochem. 1979 Jan 15;92(2):497–500. doi: 10.1016/0003-2697(79)90690-0. [DOI] [PubMed] [Google Scholar]
  4. Callander N. S., Rao L. V., Nordfang O., Sandset P. M., Warn-Cramer B., Rapaport S. I. Mechanisms of binding of recombinant extrinsic pathway inhibitor (rEPI) to cultured cell surfaces. Evidence that rEPI can bind to and inhibit factor VIIa-tissue factor complexes in the absence of factor Xa. J Biol Chem. 1992 Jan 15;267(2):876–882. [PubMed] [Google Scholar]
  5. Carson S. D., Haire W. D., Broze G. J., Jr, Novotny W. F., Pirrucello S. J., Duggan M. J. Lipoprotein associated coagulation inhibitor, factor VII, antithrombin III, and monocyte tissue factor following surgery. Thromb Haemost. 1991 Nov 1;66(5):534–539. [PubMed] [Google Scholar]
  6. Carson S. D., Ross S. E., Bach R., Guha A. An inhibitory monoclonal antibody against human tissue factor. Blood. 1987 Aug;70(2):490–493. [PubMed] [Google Scholar]
  7. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987 Apr;162(1):156–159. doi: 10.1006/abio.1987.9999. [DOI] [PubMed] [Google Scholar]
  8. Cole E. H., Schulman J., Urowitz M., Keystone E., Williams C., Levy G. A. Monocyte procoagulant activity in glomerulonephritis associated with systemic lupus erythematosus. J Clin Invest. 1985 Mar;75(3):861–868. doi: 10.1172/JCI111784. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Conkling P. R., Patton K. L., Hannun Y. A., Greenberg C. S., Weinberg J. B. Sphingosine inhibits monocyte tissue factor-initiated coagulation by altering factor VII binding. J Biol Chem. 1989 Nov 5;264(31):18440–18444. [PubMed] [Google Scholar]
  10. Edwards R. L., Rickles F. R. The role of leukocytes in the activation of blood coagulation. Semin Hematol. 1992 Jul;29(3):202–212. [PubMed] [Google Scholar]
  11. Lando P. A., Edgington T. S. An innate host response to the neoplastic cell: syngeneic rat tumor cells can elicit a rapid de novo lymphoid procoagulant response. J Immunol. 1985 Nov;135(5):3587–3595. [PubMed] [Google Scholar]
  12. Lawson J. H., Butenas S., Ribarik N., Mann K. G. Complex-dependent inhibition of factor VIIa by antithrombin III and heparin. J Biol Chem. 1993 Jan 15;268(2):767–770. [PubMed] [Google Scholar]
  13. Mann K. G., Nesheim M. E., Church W. R., Haley P., Krishnaswamy S. Surface-dependent reactions of the vitamin K-dependent enzyme complexes. Blood. 1990 Jul 1;76(1):1–16. [PubMed] [Google Scholar]
  14. McGee M. P., Li L. C. Functional difference between intrinsic and extrinsic coagulation pathways. Kinetics of factor X activation on human monocytes and alveolar macrophages. J Biol Chem. 1991 May 5;266(13):8079–8085. [PubMed] [Google Scholar]
  15. McGee M. P., Li L. C., Hensler M. Functional assembly of intrinsic coagulation proteases on monocytes and platelets. Comparison between cofactor activities induced by thrombin and factor Xa. J Exp Med. 1992 Jul 1;176(1):27–35. doi: 10.1084/jem.176.1.27. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Morrissey J. H., Fakhrai H., Edgington T. S. Molecular cloning of the cDNA for tissue factor, the cellular receptor for the initiation of the coagulation protease cascade. Cell. 1987 Jul 3;50(1):129–135. doi: 10.1016/0092-8674(87)90669-6. [DOI] [PubMed] [Google Scholar]
  17. Nawroth P. P., Handley D. A., Esmon C. T., Stern D. M. Interleukin 1 induces endothelial cell procoagulant while suppressing cell-surface anticoagulant activity. Proc Natl Acad Sci U S A. 1986 May;83(10):3460–3464. doi: 10.1073/pnas.83.10.3460. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Nemerson Y. The tissue factor pathway of blood coagulation. Semin Hematol. 1992 Jul;29(3):170–176. [PubMed] [Google Scholar]
  19. Nesheim M. E., Pittman D. D., Wang J. H., Slonosky D., Giles A. R., Kaufman R. J. The binding of 35S-labeled recombinant factor VIII to activated and unactivated human platelets. J Biol Chem. 1988 Nov 5;263(31):16467–16470. [PubMed] [Google Scholar]
  20. Nordfang O., Bjørn S. E., Valentin S., Nielsen L. S., Wildgoose P., Beck T. C., Hedner U. The C-terminus of tissue factor pathway inhibitor is essential to its anticoagulant activity. Biochemistry. 1991 Oct 29;30(43):10371–10376. doi: 10.1021/bi00107a002. [DOI] [PubMed] [Google Scholar]
  21. Novotny W. F., Girard T. J., Miletich J. P., Broze G. J., Jr Purification and characterization of the lipoprotein-associated coagulation inhibitor from human plasma. J Biol Chem. 1989 Nov 5;264(31):18832–18837. [PubMed] [Google Scholar]
  22. Rao L. V., Rapaport S. I., Hoang A. D. Binding of factor VIIa to tissue factor permits rapid antithrombin III/heparin inhibition of factor VIIa. Blood. 1993 May 15;81(10):2600–2607. [PubMed] [Google Scholar]
  23. Rothberger H., McGee M. P., Lee T. K. Tissue factor activity. A marker of alveolar macrophage maturation in rabbits. Effects of granulomatous pneumonitis. J Clin Invest. 1984 Jun;73(6):1524–1531. doi: 10.1172/JCI111358. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Sandset P. M., Abildgaard U., Larsen M. L. Heparin induces release of extrinsic coagulation pathway inhibitor (EPI). Thromb Res. 1988 Jun 15;50(6):803–813. doi: 10.1016/0049-3848(88)90340-4. [DOI] [PubMed] [Google Scholar]
  25. Sandset P. M., Warn-Cramer B. J., Maki S. L., Rapaport S. I. Immunodepletion of extrinsic pathway inhibitor sensitizes rabbits to endotoxin-induced intravascular coagulation and the generalized Shwartzman reaction. Blood. 1991 Sep 15;78(6):1496–1502. [PubMed] [Google Scholar]
  26. Sandset P. M., Warn-Cramer B. J., Rao L. V., Maki S. L., Rapaport S. I. Depletion of extrinsic pathway inhibitor (EPI) sensitizes rabbits to disseminated intravascular coagulation induced with tissue factor: evidence supporting a physiologic role for EPI as a natural anticoagulant. Proc Natl Acad Sci U S A. 1991 Feb 1;88(3):708–712. doi: 10.1073/pnas.88.3.708. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Weiss H. J., Turitto V. T., Baumgartner H. R., Nemerson Y., Hoffmann T. Evidence for the presence of tissue factor activity on subendothelium. Blood. 1989 Mar;73(4):968–975. [PubMed] [Google Scholar]
  28. Wilcox J. N., Smith K. M., Schwartz S. M., Gordon D. Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque. Proc Natl Acad Sci U S A. 1989 Apr;86(8):2839–2843. doi: 10.1073/pnas.86.8.2839. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Wun T. C., Kretzmer K. K., Girard T. J., Miletich J. P., Broze G. J., Jr Cloning and characterization of a cDNA coding for the lipoprotein-associated coagulation inhibitor shows that it consists of three tandem Kunitz-type inhibitory domains. J Biol Chem. 1988 May 5;263(13):6001–6004. [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES